Information Journal Paper
APA:
Copy. (2017). Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebocontrolled, phase 2 trial. LANCET NEUROLOGY, 16(3), 208-216. SID. https://sid.ir/paper/755110/en
Vancouver:
Copy. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebocontrolled, phase 2 trial. LANCET NEUROLOGY[Internet]. 2017;16(3):208-216. Available from: https://sid.ir/paper/755110/en
IEEE:
Copy, “Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebocontrolled, phase 2 trial,” LANCET NEUROLOGY, vol. 16, no. 3, pp. 208–216, 2017, [Online]. Available: https://sid.ir/paper/755110/en